Talal Adhami is a Gastroenterology physician affiliated with Cleveland Clinic. OpenAlex indexes 28 publications with 960 citations (h-index 7); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave A30
Cleveland, OH 441950001
Telephone
216-444-2456Registry record last updated 17 Aug 2011.
Clinical trials
- Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
Sponsor: Vital Therapies, Inc.
- Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
Sponsor: Vital Therapies, Inc.
- To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
Sponsor: Vital Therapies, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mirum Pharmaceuticals, Inc.Program year20251 payment
- Madrigal PharmaceuticalsProgram year20242 payments
- Regeneron Healthcare Solutions, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
71.8%Proton pump inhibitor38.3%Omeprazole53%Pantoprazole Sodium47%Part D<11 patientsBile Acid25.5%Ursodiol100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
11.4%Purine Antimetabolite11.4%Azathioprine100%Part D<11 patientsCardiovascular
8.7%Aldosterone antagonist (MRA)8.7%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Long-Term Effect of Weight Loss on the Prevention of Progression to Cirrhosis among Patients with Obesity and MASH-Related F3 Liver Fibrosis
International Journal of Environmental Research and Public Health
2024 - A Rare Case of Metastatic Rectal Cancer to the Brain Presenting with Headaches and Memory Difficulties
ACG Case Reports Journal
2023 - Evidence-based approach to management of hepatic encephalopathy in adults
World Journal of Hepatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Nissen, MD
Cleveland Clinic
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”